{"product_id":"oakstone-intensive-review-of-nephrology-2023","title":"Oakstone Intensive Review of Nephrology 2023","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: nephrologists, internists, pediatricians, and primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eGenetic testing for improved prognosis and therapy selection\u003c\/p\u003e\n\u003cp\u003eIntroduction to point-of-care ultrasound: fundamentals for acquisition and interpretation\u003c\/p\u003e\n\u003cp\u003ePhysical exam of the dialysis access\u003c\/p\u003e\n\u003cp\u003eExpanding the role of SGLT2i in diabetic and non-diabetic kidney disease\u003c\/p\u003e\n\u003cp\u003eCases in cryptonephrology\u003c\/p\u003e\n\u003cp\u003eThe new fundamentals in immunology and nephrology (it’s not just for transplant patients)\u003c\/p\u003e\n\u003cp\u003eand more…\u003c\/p\u003e\n\u003cp\u003eDate of Original Release: September 30, 2023\u003c\/p\u003e\n\u003cp\u003eTermination Date: January 31, 2026\u003c\/p\u003e\n\u003cp\u003eEstimated Time to Complete the Activity: 51.75 hours\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eSummarize current\/recommended nephrology guidelines in clinical practice\u003c\/p\u003e\n\u003cp\u003eExplain the differential diagnosis of complex clinical presentations of patients with renal disorders\u003c\/p\u003e\n\u003cp\u003eIdentify\/integrate current therapeutic options for specific renal disorders\u003c\/p\u003e\n\u003cp\u003eDescribe pathophysiological mechanisms as they apply to management of renal disease\u003c\/p\u003e\n\u003cp\u003eSynthesize teachings to better performance on the ABIM Nephrology certification\/recertification examinations\u003c\/p\u003e\n\u003cp\u003eACGME Competencies\u003c\/p\u003e\n\u003ch3\u003eThis course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:\u003c\/h3\u003e\n\u003cp\u003ePatient Care and Procedural Skills\u003c\/p\u003e\n\u003cp\u003eMedical Knowledge\u003c\/p\u003e\n\u003cp\u003ePractice-Based Learning and Improvement\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Renal Physiology for the Boards.mp4\u003c\/p\u003e\n\u003cp\u003e2. Basic Concepts of Immunology in Autoimmune Kidney Disease.mp4\u003c\/p\u003e\n\u003cp\u003e3. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e6. Current Approaches to Urine Sediment Analysis.mp4\u003c\/p\u003e\n\u003cp\u003e7. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e8. Pathogenesis, Diagnosis \u0026amp; Treatment of IgA Nephropathy.mp4\u003c\/p\u003e\n\u003cp\u003e9. Metabolic Management of Kidney Stones.mp4\u003c\/p\u003e\n\u003cp\u003e11. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e12. Update on Lupus Nephritis.mp4\u003c\/p\u003e\n\u003cp\u003e13. Membranous Nephropathy.mp4\u003c\/p\u003e\n\u003cp\u003e15. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e18. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e19. Hyponatremia \u0026amp; Hypernatremia.mp4\u003c\/p\u003e\n\u003cp\u003e20. Hypokalemia \u0026amp; Hyperkalemia.mp4\u003c\/p\u003e\n\u003cp\u003e21. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e22. Important New Trials in Glomerular Disease.mp4\u003c\/p\u003e\n\u003cp\u003e23. Genetics \u0026amp; Kidney Disease.mp4\u003c\/p\u003e\n\u003cp\u003e24. Update on Polycystic Kidney Disease.mp4\u003c\/p\u003e\n\u003cp\u003e25. Pediatric Nephrology.mp4\u003c\/p\u003e\n\u003cp\u003e27. Rapidly Progressive Glomerulonephritis.mp4\u003c\/p\u003e\n\u003cp\u003e28. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e29. Why Do We Reject a Transplant.mp4\u003c\/p\u003e\n\u003cp\u003e30. Transplant Immunosuppression for the Boards.mp4\u003c\/p\u003e\n\u003cp\u003e31. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e34. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e35. Donor Evaluation.mp4\u003c\/p\u003e\n\u003cp\u003e36. Late Loss of the Kidney Transplant.mp4\u003c\/p\u003e\n\u003cp\u003e37. Infections in Transplant Recipients.mp4\u003c\/p\u003e\n\u003cp\u003e40. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e43. Hemolytic Uremic Syndrome (HUS) \u0026amp; Thrombotic Thrombocytopenic Purpura (TTP).mp4\u003c\/p\u003e\n\u003cp\u003e44. Geriatric Nephrology.mp4\u003c\/p\u003e\n\u003cp\u003e45. Pathophysiology \u0026amp; Treatment of Diabetic Kidney Disease.mp4\u003c\/p\u003e\n\u003cp\u003e47. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e48. Primary Aldosteronism.mp4\u003c\/p\u003e\n\u003cp\u003e50. Liver \u0026amp; the Kidney.mp4\u003c\/p\u003e\n\u003cp\u003e51. Pathophysiology of Acute Kidney Injury.mp4\u003c\/p\u003e\n\u003cp\u003e52. Acute Kidney Injury Syndromes.mp4\u003c\/p\u003e\n\u003cp\u003e53. ICU Nephrology \u0026amp; Continuous Renal Replacement Therapies.mp4\u003c\/p\u003e\n\u003cp\u003e54. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e55. Acute Kidney Injury in Cancer.mp4\u003c\/p\u003e\n\u003cp\u003e57. Therapy of Focal \u0026amp; Segmental Glomerulosclerosis (FSGS) Lesions in 2023.mp4\u003c\/p\u003e\n\u003cp\u003e59. APOL1 \u0026amp; Kidney Disease.mp4\u003c\/p\u003e\n\u003cp\u003e60. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e63. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e65. Pearls in Mineral \u0026amp; Bone Disease.mp4\u003c\/p\u003e\n\u003cp\u003e66. Chronic Kidney Disease Epidemiology.mp4\u003c\/p\u003e\n\u003cp\u003e67. Question \u0026amp; Answer Session.mp4\u003c\/p\u003e\n\u003cp\u003e68. Introduction to Peritoneal Dialysis.mp4\u003c\/p\u003e\n\u003cp\u003e69. Complications of Peritoneal Dialysis.mp4\u003c\/p\u003e\n\u003cp\u003e70. Acute Kidney Injury Related to Immune Checkpoint Inhibitors.mp4\u003c\/p\u003e\n\u003cp\u003e71. Mesoamerican Nephropathy.mp4\u003c\/p\u003e\n\u003cp\u003e72. Renal Ultrasound for the Clinical Nephrologist.mp4\u003c\/p\u003e\n\u003cp\u003e80. Update on Renovascular Disease.mp4\u003c\/p\u003e\n\u003cp\u003e82. Immunologic Basis of Kidney Disease.mp4\u003c\/p\u003e\n\u003cp\u003e83. Use of Checkpoint Inhibitors in Kidney Transplant Recipients.mp4\u003c\/p\u003e\n\u003cp\u003e85. Ethics in Nephrology.mp4\u003c\/p\u003e\n\u003cp\u003e86. Pregnancy \u0026amp; Renal Disease.mp4\u003c\/p\u003e\n\u003cp\u003eQuestions.pdf\u003c\/p\u003e\n\u003cp\u003eSyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405737382084,"sku":null,"price":13.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Oakstone-Intensive-Review-of-Nephrology-2023.jpg?v=1784215493","url":"https:\/\/medicalcoursespro.com\/products\/oakstone-intensive-review-of-nephrology-2023","provider":"Medicalcoursespro","version":"1.0","type":"link"}